All In Biotech

Drug Trial Radar · NCT06128369

A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Opthalmic Suspension Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

A Randomized, Double-masked, Vehicle-controlled Study Evaluating the Efficacy and Safety of OCS-01 Ophthalmic Suspension in the Treatment of Inflammation and Pain Following Cataract Surgery

Last checked: Nov 19, 2026Latest source record: Jul 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 117 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

117

Actual

Start

Dec 18, 2023

Primary completion

May 2, 2024

Study completion May 9, 2024

Sponsor

Lead sponsor
OculisIndustry
Sponsor type
Industry
First posted
Nov 13, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This was a randomized, double-masked, vehicle-controlled, Phase 3 study evaluating the efficacy and safety of OCS-01 QD compared to vehicle in the treatment of inflammation and pain following cataract surgery.

Conditions

  • Inflammation Eye Pain
  • Postoperative Cataract

Interventions

  • OCS-01Drug

    Dexamethasone ophthalmic suspension, 1.5%

  • VehicleDrug

    Vehicle

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Absence of Anterior Chamber Cells at Visit 6.Time frame: Day 15.
  2. Absence of Ocular Pain at Visit 4.Time frame: Day 4.

Locations

24 sites in 1 country. Site status is shown where the registry gives one.

  • Oculis Investigative Site

    Glendale, California

  • Oculis Investigative Site

    Inglewood, California

  • Oculis Investigative Site

    Newport Beach, California

  • Oculis Investigative Site

    Torrance, California

  • Oculis Investigative Site

    Tamarac, Florida

  • Oculis Investigative Site

    Morrow, Georgia

  • Oculis Investigative Site

    Northbrook, Illinois

  • Oculis Investigative Site

    Indianapolis, Indiana

  • Oculis Investigative Site

    Louisville, Kentucky

  • Oculis Investigative Site

    Woburn, Massachusetts

  • Oculis Investigative Site

    St Louis, Missouri

  • Oculis Investigative Site

    Washington, Missouri

  • Oculis Investigative Site

    Las Vegas, Nevada

  • Oculis Investigative Site

    Elizabeth City, North Carolina

  • Oculis Investigative Site

    Leland, North Carolina

  • Oculis Investigative Site

    Cincinnati, Ohio

  • Oculis Investigative Site

    Eugene, Oregon

  • Oculis Investigative Site

    Erie, Pennsylvania

  • Oculis Investigative Site

    Kingston, Pennsylvania

  • Oculis Investigative Site

    Nashville, Tennessee

  • Oculis Investigative Site

    Austin, Texas

  • Oculis Investigative Site

    Houston, Texas

  • Oculis Investigative Site

    San Antonio, Texas

  • Oculis Investigative Site

    Lynchburg, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.